Trials of Gilead Coronavirus Drug in China Could Start Next Week

(Bloomberg) -- Gilead Sciences Inc. is shipping enough doses of its experimental coronavirus drug to treat 500 patients in China and is ramping up supply in case clinical trials work.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.